STS and PUDP Deletion Identified by Targeted Panel Sequencing with CNV Analysis in X-Linked Ichthyosis: A Case Report and Literature Review

Genes (Basel). 2023 Oct 10;14(10):1925. doi: 10.3390/genes14101925.

Abstract

X-linked recessive ichthyosis (XLI) is clinically characterized by dark brown, widespread dryness with polygonal scales. We describe the identification of STS and PUDP deletions using targeted panel sequencing combined with copy-number variation (CNV) analysis in XLI. A 9-month-old infant was admitted for genetic counseling. Since the second day after birth, the infant's skin tended to be dry and polygonal scales had accumulated over the abdomen and upper extremities. The infant's maternal uncle and brother (who had also exhibited similar skin symptoms from birth) presented with polygonal scales on their trunks. CNV analysis revealed a hemizygous deletion spanning 719.3 Kb on chromosome Xp22 (chrX:7,108,996-7,828,312), which included a segment of the STS gene and exhibited a Z ratio of -2 in the proband. Multiplex ligation-dependent probe amplification (MLPA) confirmed this interstitial Xp22.31 deletion. Our report underscores the importance of implementing CNV screening techniques, including sequencing data analysis and gene dosage assays such as MLPA, to detect substantial deletions that encompass the STS gene region of Xq22 in individuals suspected of having XLI.

Keywords: MLPA; PUDP gene; STS gene; X-linked ichthyosis; copy-number variation; hemizygous deletion; targeted panel sequencing.

Publication types

  • Review
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Copy Number Variations / genetics
  • Humans
  • Ichthyosis, X-Linked* / diagnosis
  • Ichthyosis, X-Linked* / genetics
  • Infant
  • Male
  • Multiplex Polymerase Chain Reaction
  • Skin
  • Steryl-Sulfatase* / genetics

Substances

  • Steryl-Sulfatase
  • PUDP protein, human
  • STS protein, human

Grants and funding

This article was supported by research funds for newly appointed professors of Jeonbuk National University in 2020. This research was supported by the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. RS-2023-00236157).